Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof

A technology of staphylococcus aureus and staphylococcus, applied in the field of bioengineering, can solve problems such as multi-drug resistance, difficult clinical treatment, and drug resistance of staphylococcus aureus

Active Publication Date: 2012-09-19
JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
View PDF2 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With the widespread use of antibiotics, Staphylococcus aureus not only develops resistance to antibiotics, but also exhibits multi-drug resistance, which brings great difficulties to clinical treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof
  • Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof
  • Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Phage Isolation Preparation and Genome Extraction

[0046] Phage isolation and preparation

[0047] The sample of the present invention is collected from the milk sample of Xigang Dairy Farm in Nanjing, Jiangsu. In the milk sample, add 1ml of Staphylococcus aureus overnight culture, then add sterile CaCl 2 After mixing the mother liquor to a final concentration of 1.25mM, add 20ml TSB-YE medium, let it react at room temperature for 30min, and then place it at 30°C. -1 , 4°C, centrifuge for 30 min, take the supernatant; then filter the supernatant with a 0.22 μm filter membrane to form a phage stock solution.

[0048] Take 0.1ml of bacteriophage stock solution, carry out 10-fold dilution, take 10 2 、10 4 and 10 6 Mix 0.1ml each of the dilution solution with 0.1ml of the overnight cultured host bacterial solution. After 15 minutes at room temperature, add about 5ml of 0.7% LB medium. It was solidified, placed in an incubator at 30° C. for 12 hours, and then...

Embodiment 2

[0052] Embodiment 2: LysM9 gene ( lys M9) cloning and expression vector construction

[0053] a. Design a pair of specific primers according to the LysM9 gene coding sequence:

[0054]M9-1: 5’- ATT GGA TCC GGT AGG TGT TGA CCA ATG TTG -3', see SEQ ID NO.3;

[0055] M9-2: 5’-CTT AAG CTT TAA ATC GTG CTA AAC TTA CC -3', see SEQ ID NO.4; use the phage genome as a template to amplify the full-length sequence of the LysM9 gene with the above-mentioned specific primers, electrophoresis on 1% agarose, and identify the size of the amplified fragment;

[0056] b. Gel cutting recovery (1.5kb fragment) to amplify the correct target fragment, the gel recovery kit will purify and recover the fragment, and connect the fragment to the pMD18-T vector overnight at 16°C, and transform Escherichia coli DH5α competent cells the next day , smeared on a plate containing ampicillin (100 μg / ml), and sequenced and identified the transformed positive clone, named it LysM9 gene, and its nucleotide...

Embodiment 3

[0061] Example 3: Induced expression and purification of LysM9 protein

[0062] The recombinant strain DE3 (pET-lysM9) was inoculated into LB culture medium containing kanapenicillin (100 μg / mL), and cultured overnight at 37°C with shaking; the next day, it was transferred to 100 mL LB medium at a ratio of 1:100, Shake culture at 37℃ to OD 600 When the value is about 0.5, add IPTG to a final concentration of 1 mmol / L, and induce at 28°C for 5 h. Collect the bacteria, disrupt the cells by ultrasonic, centrifuge at 10,000 rpm / min at 4°C for 10 min, collect the supernatant, filter the supernatant through a 0.22 μm filter membrane, and analyze the protein expression in the lysed supernatant by SDS-PAGE. The filtered lysed supernatant was purified by His affinity chromatography nickel column (GE Healthcare, Sweden), specifically according to the instructions of the kit. The obtained protein was named lysM9, and the purified lysM9 product was detoxified (≤0.01 EU / μg endotoxin) wit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biological engineering, and in particular relates to lywallzyme (or catenase) of phage of staphylococcus aureus and an application thereof as an antibacterial material in preventing and treating bouine mastitis and controlling food pollution. The amino acid sequence of the lywallzyme of phage of staphylococcus aureus is SeqIDNO2. Zymin capable of efficiently killing staphylococcus aureus is developed by a bioengineering technique. The zymin can be used independently or with other agents to inactivate staphylococcus aureus specifically so as to provide a safe zymin source without toxic and side effects for preventing and treating bouine mastitis and controlling staphylococcus aureus pollution in food.

Description

technical field [0001] The invention belongs to the field of bioengineering, in particular to a Staphylococcus aureus bacteriophage lysase (or lyase) and its application as an antibacterial substance in the prevention of dairy cow mastitis and the control of food pollution. [0002] Background technique [0003] Cow mastitis not only brings huge economic losses to the world dairy industry, but also endangers public health and human health. Research data show that Staphylococcus aureus is the main pathogenic bacteria causing mastitis in dairy cows, and the cases of mastitis in cows caused by it reach 74%. Up to 350 million. [0004] The main cause of mastitis in dairy cows is the infection of pathogenic microorganisms, among which Staphylococcus aureus ( Staphyloccus aureus ), Streptococcus and Escherichia coli, accounting for more than 90% of cow mastitis cases. Among them, SA is the most important pathogen causing mastitis, and it is also the most difficult to treat cli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/88C12N15/60C12N15/63C12N1/15C12N1/19C12N1/21A23B4/22A23B5/16A23B9/28A23B7/155A23C9/12A23L3/3571A61K38/51A61P31/04
Inventor 张辉王冉包红朵
Owner JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products